Market Overview - On January 26, A-shares saw a collective decline with the Shanghai Composite Index down 0.09% at 4132 points, the Shenzhen Component down 0.85%, and the ChiNext Index down 0.91% [1][2] - The total market turnover reached 3.28 trillion yuan, an increase of 162.5 billion yuan compared to the previous trading day, with over 3700 stocks declining [1] Sector Performance - The commercial aerospace and satellite internet sectors experienced significant pullbacks, with stocks like China Satellite and Aerospace Development hitting the daily limit down [2][4] - The military industry sector also fell, with stocks such as Chaojie Co. dropping over 10% [2] - Conversely, international gold and silver prices surged to new highs, leading to a rally in precious metals and non-ferrous metals sectors, with stocks like Xiaocheng Technology and Western Gold hitting the daily limit up [2][10] - The outbreak of the Nipah virus in India caused a collective rise in the biopharmaceutical and vaccine sectors [2][14] Notable Stock Movements - In the military equipment sector, Aerospace Hanyu fell over 11%, while China Satellite and Aerospace Technology hit the daily limit down [4] - In the semiconductor equipment sector, stocks like Su Dawei and Wo Ge Optoelectronics saw significant declines, with some stocks dropping over 11% [5][8] - The humanoid robot sector also faced declines, with stocks like Haoshi Machinery and Lixing Co. dropping over 13% [6][9] - The biopharmaceutical sector saw notable gains, with stocks like Hualan Vaccine and Jindike hitting the daily limit up due to the Nipah virus outbreak [14] Investment Insights - The coal sector showed strength, with China Shenhua rising over 4% and other coal stocks following suit [18] - The insurance sector also performed well, with stocks like New China Life and China Pacific Insurance seeing gains [15][16] - The market outlook suggests a focus on sectors with performance verification, particularly in price increase chains, high-end manufacturing, and AI-related industries [19]

报道称，当地政府正采取措施遏制病毒传播，目前已有近百人被要求居家隔离。由于该病毒通常由蝙蝠 传染给人类，西孟加拉邦已要求该邦多个动物园对圈养的蝙蝠进行采样检测。 世卫组织公布的信息显示，自1998年以来，孟加拉国、印度、马来西亚、菲律宾和新加坡均报告过尼帕 病毒疫情。印度自2001年以来多次出现尼帕病毒疫情。2025年5月17日至7月12日期间，印度喀拉拉邦报 告了4例尼帕病毒感染病例，其中包括2例死亡病例。 生物疫苗概念26日盘中走势强劲，截至发稿，华兰疫苗、金迪克20%涨停，智飞生物涨超15%，沃森生 物、康希诺等涨超10%。 消息面上，据印度媒体报道，印度东部的西孟加拉邦近期出现尼帕病毒疫情，确诊病例已升至5例。感 染者正在该邦首府加尔各答及周边医院接受治疗，其中一名患者病情危重。 （文章来源：证券时报网） ...

Market Performance - The Shanghai Composite Index experienced a slight decline of 0.09%, while the Shenzhen Component Index and the ChiNext Index fell by 0.85% and 0.91% respectively [1] - The total market turnover reached 3.28 trillion yuan, with over 1,600 stocks rising [1] Sector Highlights - The gold sector showed strong performance, with stocks such as Hunan Gold, Shengda Resources, Sichuan Gold, and China Gold hitting the daily limit [1] - Resource sectors including oil, coal, and gas were active, with stocks like Heshun Petroleum and Intercontinental Oil & Gas also reaching the daily limit [1] - The virus prevention concept saw a surge, with stocks like Maike Biological, Kaipu Biological, Zhijiang Biological, and Hualan Vaccine hitting the daily limit [1] Sector Declines - Sectors such as electric machinery, automotive parts, semiconductors, communication equipment, satellite internet, robotic actuators, and commercial aerospace experienced notable declines [1]

Core Viewpoint - The A-share market saw a significant rise in vaccine stocks, driven by the outbreak of the Nipah virus in West Bengal, India, which has a high mortality rate and no available vaccine [1][2]. Group 1: Market Performance - Hualan Vaccine and Jindike both reached the daily limit of 20% increase, while Zhifei Biological rose over 15%, Kangle Health over 13%, and CanSino over 12% [1]. - Other notable increases included Watson Bio with a rise of over 10%, Kangtai Bio by nearly 7%, and Wantai Bio by almost 6% [1]. - The total market capitalization for Hualan Vaccine is 14 billion, Jindike is 3.11 billion, and Zhifei Biological is 47.7 billion [2]. Group 2: Year-to-Date Performance - Year-to-date, Hualan Vaccine has increased by 25.28%, Jindike by 24.96%, and Kangle Health by 36.15% [2]. - Zhifei Biological has a year-to-date increase of 5.67%, while Watson Bio has risen by 32.24% [2]. - Kangtai Bio's year-to-date increase stands at 16.59%, and Wantai Bio at 4.47% [2]. Group 3: Industry Context - The Nipah virus outbreak has prompted the Thai Civil Aviation Authority to implement comprehensive screening for flights from West Bengal to prevent the virus from entering Thailand [1]. - Jindike has acknowledged awareness of the Nipah virus news but stated that the company does not have related products [1].

盘面上，大金融板块护盘，券商、保险等方向领涨；资源股强势，其中，有色、贵金属概念持续爆发， 四川黄金等多股涨停，煤炭、油气板块走强，中国海油创历史新高，中国神华等股走高；化工板块拉 升，红宝丽涨停；生物疫苗、抗病毒、流感等医药股全线上涨，华兰疫苗等多股涨停。下跌方面，热门 板块和个股集体杀跌，半导体芯片、商业航天、机器人、AI应用等方向跌幅居前，中国卫星触及跌 停；此外，白酒板块下挫，洋河股份创8年多新低。 展望后市，中信证券认为，市场信心持续恢复过程中，只要在相对低位、能讲出逻辑且不在宽基权重的 行业预计都可能将修复。 从个股看，两市上涨1604家，下跌3771家，98家涨幅持平。两市共79股涨停，共42股跌停。 今日市场放量震荡，三大指数集体收跌，创业板指、科创50指数调整明显。市场连续两个交易日成交超 3万亿，较上个交易日放量超千亿，两市下跌个股超3700只。 截至收盘，沪指跌0.09%报4132.61点，成交14519亿元；深成指跌0.85%报14316.64点，成交17964亿 元。创业板指下跌0.91%，报3319.15点。 据券商中国，代表风险偏好的两大变量集体来袭。一是地缘风险加剧和美元指数杀 ...

Market Overview - The Shanghai Composite Index experienced a slight decline of 0.09% while the Shenzhen Component Index and the ChiNext Index fell by 0.85% and 0.91% respectively [1] - The total market turnover reached 3.28 trillion yuan, with over 1,600 stocks rising [1] Sector Performance - The gold sector showed strong performance, with multiple stocks such as Hunan Gold, Shengda Resources, Sichuan Gold, and China Gold hitting the daily limit [1] - Resource sectors including oil, coal, and gas were active, with stocks like Heshun Petroleum and Intercontinental Oil & Gas also reaching the daily limit [1] - The virus prevention sector saw a surge, with stocks like Maike Biology, Cape Biology, Zhijiang Biology, and Hualan Vaccine hitting the daily limit [1] Declining Sectors - Sectors such as electric motors, automotive parts, semiconductors, communication equipment, satellite internet, robotic actuators, and commercial aerospace experienced declines [1] - The overall market showed a mixed performance with certain sectors like mining, small metals, non-ferrous metals, insurance, fertilizers, securities, and titanium dioxide showing gains [1]

Core Viewpoint - The A-share market saw a significant rise in vaccine stocks due to the outbreak of the Nipah virus in West Bengal, India, which has a high mortality rate and no available vaccine [1] Group 1: Market Performance - Vaccine stocks such as Hualan Biological, Gendik, and Zhifei Biological experienced substantial gains, with Gendik hitting the 20% limit up, Zhifei Biological rising over 15%, and Kangle Health increasing by over 13% [1] - Other notable increases included CanSino Biologics up by over 12%, Watson Biotech by over 10%, and Kangtai Biological by over 7% [1] Group 2: Company Specifics - Gendik acknowledged awareness of the Nipah virus news but stated that the company does not have related products [1] - The total market capitalization of leading vaccine companies includes Zhifei Biological at 477 billion, Watson Biotech at 230 billion, and CanSino Biologics at 192 billion [2]

今日午后开盘，疫苗概念快速拉升，疫苗、生物医药、创新药等细分领域表现亮眼，截至发稿，疫苗 ETF富国（159645）盘中涨3.87%，其成分股华兰疫苗涨20%，万孚生物涨超17%，智飞生物涨超13%。 消息面上，华兰疫苗发布公告，公司重组带状疱疹疫苗于近日获得国家药品监督管理局颁发的药物临床 试验批准通知书，获准开展临床试验。该进展被视为公司在重要预防领域管线布局的关键突破。市场预 期随着国内老龄化进程加快，带状疱疹疫苗接种需求增长空间较大。 疫苗ETF富国（159645）紧密跟踪国证疫苗与生物科技指数（980015）指数，指数由业务涉及生物科技 产业的50家A股上市公司组成，反映A股市场的生物科技产业中优质上市公司的整体表现，帮助投资者 精准捕捉医疗疫苗领域投资机会。 （文章来源：每日经济新闻） 相关机构表示，长期来看，疫苗渗透率提升叠加人口老龄化进程加快，如带状疱疹疫苗接种需求增长空 间较大。而国内创新型疫苗的加速审批上市、鼓励疫苗研发投入加大等相关政策的陆续发布，也将推动 我国疫苗行业快速发展。此外，疫苗出海也为疫苗行业拓宽了需求领域，近期海外如印度西孟加拉邦暴 发尼帕病毒疫情也引发关注。 ...

Group 1 - The flu sector experienced a significant surge, with Cap Bio (300639) hitting the daily limit of 20% increase in less than a minute, while other companies like Mike Bio, Jindike, and Oriental Bio rose over 10% [1] - Cap Bio opened at 6.12 and reached a high of 7.25, reflecting a 20.03% increase, with a total market value of 46.87 billion and a circulating market value of 46.05 billion [2][3] - Other notable performers in the flu sector included Hualan Vaccine, which increased by 20%, Mike Bio by 15.22%, and Jindike by 13.62% [3][4] Group 2 - Reports indicated that there are confirmed cases of Nipah virus infection in West Bengal, India, with five cases reported, including healthcare workers, leading to nearly 100 individuals being quarantined [4]

A股市场 生物医药股全线上涨，其中，康乐卫士涨超20%， 迈克生物、 凯普生物、 之江生物、 华兰疫 苗20CM涨停， 金迪克、 智飞生物涨超13%， 康希诺、 百普赛斯涨超12%， 东方生物涨超11%， 沃森 生物、 圣湘生物涨超10%， 达安基因、 科华生物10CM涨停， 康泰生物、 泓博医药涨超7%。 ...